On December 15th and 16th, SHL held a donation event for new or second-hand items to be donated to Indigenous children of remote areas on the Eastern coast of Taiwan, namely in Taitung and Hualien. Indigenous children in these remote areas have limited resources to supplies needed for going to school, which includes backpacks, lunch boxes, pencils, coloring pens, etc.
This Christmas, SHL partnered up with South-Link Health Care Promotion Association of Taitung County, which was founded by Dr. Hsu Chao-Pin to provide better resource access for those in need located in the East coast. The foundation began the “Ark Sunshine” program, which mainly assists five elementary schools with educational resources.
During the two-day donation event, gifts and items poured in from SHL employees, all very eager to help out. There were numerous backpacks with cartoon characters on them, shiny new lunch boxes and an array of new pens and markers. Many staff members pooled in to buy new school supplies for the children.
Following one of our core values – We Care – not only is it important for the company to value its people, but also for the people at the company to value the well-being of others; regularly incorporating CSR (Corporate Social Responsibility) events reinforces our values and encourages goodwill.
SHL designs, develops and manufactures advanced drug delivery devices such as auto injectors and pen injectors, which are meant to improve the quality of life for patients around the world. There are less-privileged people all over the world, but for this holiday season, SHL is making Christmas for many of the Indigenous children of Taiwan a little more special.
SHL is a world-leading solution provider in the design, development and manufacturing of advanced drug delivery devices such as auto injectors and pen injectors. With locations in Taiwan, Sweden and the US, our experienced engineers and designers develop product enhancements and breakthrough drug delivery solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of “next-generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.
With over 3,700 staff worldwide, our organization consists of several distinct group companies:
SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe
SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use
SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products
For additional information visit www.shl.group